LynxCare

✨ Exciting times ahead! In less than 4 weeks, we’ll be attending #ESMO2024 in Barcelona.   While the venue impresses with its cutting-edge sustainable design —featuring one of the largest rooftop photovoltaic plants in Europe — our two joint posters are ready to shine just as bright! 🌞   We’re thrilled to be presenting our multi-center real-world studies that delve into the 𝐢𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐢𝐦𝐦𝐮𝐧𝐞 𝐜𝐡𝐞𝐜𝐤𝐩𝐨𝐢𝐧𝐭 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬 (ICIs) in treating real-world #cancer patients.   W̳i̳l̳l̳ ̳y̳o̳u̳ ̳b̳e̳ ̳t̳h̳e̳r̳e̳?̳ 𝐋𝐞𝐭’𝐬 𝐜𝐨𝐧𝐧𝐞𝐜𝐭 if you’re attending! You can schedule a meeting through our online agenda, or simply reach out to grab a coffee ☕ in Barcelona. ➡️ https://lnkd.in/eU5xtkMb   Stay tuned for the reveal of our posters - just a little more patience needed!   #ImmunoOncology #RealWorldData #RealWorldEvidence

🌟 Driving Innovation in Mental Health. We are thrilled to share the successful completion of a pilot project in collaboration with Obasi, and supported by Johnson & Johnson!   Our mission? To empower psychiatric hospitals to unlock the full potential of their clinical data, leveraging LynxCare's #NLP-#AI technology. By transforming this data into actionable insights, we're shedding light on the full patient journey, from treatment patterns to disease progression and outcomes. This innovative approach paves the way for significant advances in both treatment and medical #research in #MentalHealth.   Ready to innovate? Learn more in the attached article (English and French versions also available). #Psychiatry #RealWorldEvidence #RealWorldData

Analysis of Lung Cancer Patient Treatment with Immune Checkpoint Inhibitors Using Natural Language Processing for Data Extraction from Electronic Health Records #OHDSISocialShowcase #JoinTheJourney Lead: Iege Bassez Team: Laura Deckx, Vincent Geldhof, Annelies Verbiest, Danielle Delombaerde, Shahbaz Pervaiz, Dries Hens , M.D., Philip Debruyne, Christof Vulsteke, Clara L. Oeste https://lnkd.in/eJUgdUYp

Every year, #WorldLungCancerDay is observed on August 1st to raise awareness about #LungCancer, create a platform to deepen our knowledge, and foster research. 🔬 𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐋𝐮𝐧𝐠 𝐂𝐚𝐧𝐜𝐞𝐫 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡: 𝐀 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐯𝐞 𝐀𝐩𝐩𝐫𝐨𝐚𝐜𝐡 At the European Lung Cancer Congress earlier this year, we proudly presented our multicenter study with 3 hospitals on real-world treatment practices for lung cancer patients receiving immune checkpoint inhibitors. 📊 Through our #AI-#NLP #technology, we were able to analyze an impressive 597 variables from full EHRs, generating a highly granular #OMOP-CDM database giving insights into the lung cancer patient pathway. With this #innovative approach, we helped unlock valuable clinical insights, paving the way for more effective treatments and enhanced patient outcomes. Together, we can make a difference in the fight against lung cancer. 💪 AZ Maria Middelares, az groeninge, UZA #RealWorldEvidence #RWE #Oncology #ImmunoOncology

🚀 #ESMO2024 - here we come! Proud to showcase our multi-center real-world studies on growing the understanding of immune checkpoint inhibitors (ICIs) treatment in real-world #cancer patients through two impactful joint posters. 🔍 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: Our innovative #NLP, finetuned on disease-specific EHRs, excels at mining unstructured data from clinical notes, providing a richer and more accurate picture of adverse events in cancer patients treated with ICIs. Our approach uncovers critical information on the risk benefit-balance of these treatments and builds this view at an unprecedented high-definition level. 𝐌𝐨𝐫𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐜𝐨𝐦𝐢𝐧𝐠 𝐬𝐨𝐨𝐧! Join us at ESMO 2024 to explore how our cutting-edge #technology is transforming cancer #research and improving patient outcomes with unparalleled precision. Contact us to learn more! https://lnkd.in/eU5xtkMb UZA , az groeninge, AZ Maria Middelares #Oncology #ImmunoOncology #RealWorldEvidence 

🚀Proud to share that we've been recognized as one of the World's Best #Digital #Health Companies by Newsweek and Statista! Among the 400 companies from 35 countries featured on the list, we are excited to be one of the two Belgian companies honored. This recognition is a testament to our commitment to #innovation and excellence to transforming #healthcare through cutting-edge #technology. 💡 The comprehensive evaluation, which reviewed over 3,000 companies globally, considered the impact of our product and services, leadership expertise, financial performance, and online engagement. A big thank you to our incredible team, customers and partners. 🙌 Curious about boosting your research and enhancing patient care with deep clinical insights from full EHRs? Visit https://www.lynx.care or reach out https://lnkd.in/dn_FXMau. We are happy to tell you more about the transformative power of our clinical #AI-#NLP pipelines. Explore the full ranking here: https://lnkd.in/gsjf7JTU

We are excited to announce Jeanne Kehren as our new Chief Executive Officer. Jeanne succeeds our visionary founder, Georges De Feu, who decided to step aside from his role as CEO. We thank Georges for his foundational contributions. As LynxCare continues to grow, we recognize the importance of bringing in specific experience and leadership to drive us through our next phase of development. With Jeanne, we bring onboard a profound expertise in innovative #healthcare #data solutions and experience in accelerating pharmaceutical #innovation through #technology. 𝐌𝐞𝐞𝐭 𝐉𝐞𝐚𝐧𝐧𝐞 Jeanne began her career at Novartis, enhancing R&D with innovative technologies and data integration. She joined Sanofi in 2009, leading major projects and later reshaping portfolios and strategies. In 2019, she became a Bayer, Pharma Executive committee member heading Digital & Commercial Innovation and added the role of Chief Information Officer Pharmaceuticals in 2021 until end of last year. We are confident that Jeanne’s leadership will propel us to new heights, while continuing to deliver innovative health data solutions and drive success for our clients and partners. Join us in welcoming Jeanne to LynxCare! 🌟 Click here to read the full communication: https://lnkd.in/e7zPGdJR

Throwback to the magnificent 5th edition of the European #OHDSI Symposium! It was a pleasure to attend, contribute, present and get inspired by the many other innovative European initiatives using the #OMOP CDM. 📊🔬 Our collaborative poster with az groeninge, AZ Maria Middelares and UZA is still available for download: https://lnkd.in/eRxkgJdz The poster discusses the initial results from a study into #LungCancer patients treated with Immune Checkpoint Inhibitors using #NLP for data extraction from EHRs. 📸 Below some snapshots from the symposium. Looking forward to next year's edition! #RealWorldEvidence #RWE #EHDS OHDSI (Observational Health Data Sciences & Informatics)

See you at the #OHDSIEurope symposium today! 🌟   📅 𝐌𝐚𝐫𝐤 𝐲𝐨𝐮𝐫 𝐚𝐠𝐞𝐧𝐝𝐚 T̳i̳m̳e̳: 11h30 – 12h45 T̳o̳p̳i̳c̳: Analysis of Lung Cancer Patient Treatment with Immune Checkpoint Inhibitors Using Natural Language Processing for Data Extraction from Electronic Health Records S̳p̳e̳a̳k̳e̳r̳s̳: Clara L. Oeste (LynxCare), Annelies Verbiest (UZA)   👁️ And keep your eyes open for our joint poster with UZA, AZ Maria Middelares and az groeninge! 📥 Great news for those who cannot make it - the poster is now available for download: https://lnkd.in/eRxkgJdz #ImmunoOncology #Oncology #LungCancer

📢 Do not miss our joint poster with AZ Maria Middelares, az groeninge and UZA, featured at the #OHDSI Europe symposium next Monday!   Join us to explore our collaborative efforts and insights into #oncology research, focusing on lung #cancer patients treated with immune checkpoint inhibitors (ICI). 📊🔬   A huge thank you to all authors and contributors, incl. Iege Bassez, Laura Deckx, Vincent Geldhof, Annelies Verbiest, Danielle Delombaerde, Shahbaz Pervaiz, Dries Hens , M.D., Philip Debruyne, Christof Vulsteke, and Clara L. Oeste.   Eager to receive a copy of our poster? 📥 It will soon become available for download in the LynxCare Knowledge Center.   📰 If you’d like to receive LynxCare updates directly in your inbox, sign up for our monthly newsletter here: https://lnkd.in/ephmSYP2 OHDSI Belgium